Use the Back button in your browser to see the other results of your search or to select another record.
Cost-savings analysis of an individualized exercise oncology program in early-stage breast cancer survivors: a randomized clinical control trial [with consumer summary] |
Wonders KY, Schmitz K, Wise R, Hale R |
JCO Oncology Practice 2022 Jul;18(7):e1170-e1180 |
clinical trial |
6/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Copyright release for this abstract has not been granted.
|